rx 336m has been researched along with ag 3-5 in 1 studies
| Studies (rx 336m) | Trials (rx 336m) | Recent Studies (post-2010) (rx 336m) | Studies (ag 3-5) | Trials (ag 3-5) | Recent Studies (post-2010) (ag 3-5) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 126 | 0 | 66 |
| Protein | Taxonomy | rx 336m (IC50) | ag 3-5 (IC50) |
|---|---|---|---|
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | 0.058 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cowan, A | 1 |
1 other study(ies) available for rx 336m and ag 3-5
| Article | Year |
|---|---|
RX 336-M, a new chemical tool in the analysis of the quasi-morphine withdrawal syndrome.
Topics: Animals; Codeine; Drug Tolerance; Humans; Hydroxamic Acids; Male; Morphine Dependence; Pyrimidinones; Rats; Shivering; Structure-Activity Relationship; Substance Withdrawal Syndrome; Thyrotropin-Releasing Hormone; Valproic Acid | 1981 |